Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Nefrologia|December 17, 2019
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional studyFrancisco Valga, Tania Monzón, Fernando Henriquez, et al.Nefrologia|July 9, 2021
Inflammation and hemodialysis adequacy: Are C-reactive protein levels influenced by dialysis dose?Francisco Valga, Tania Monzón, Nicanor Vega-Diaz, et al.Nefrologia|September 26, 2022
Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis?Francisco Valga, Tania Monzón, Nicanor Vega-Diaz, et al.Clinical Kidney Journal|July 3, 2023
Expanded hemodialysis: what's up, Doc?Ana García-Prieto, José Carlos de la Flor, Elisabet Coll, et al.Case Reports in Nephrology|March 22, 2021
Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 CasesJosé C De La Flor, Francisco Valga, Alexander Marschall, et al.Case Reports in Nephrology and Dialysis|December 5, 2022
Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental HemodialysisJosé C De la Flor, Javier Deira Lorenzo, Alexander Marschall, et al.Nefrologia|January 20, 2024
Serum chloride as a marker of cardiovascular and all-cause mortality in chronic hemodialysis patients: 5-Year follow-up studyFrancisco Valga, Tania Monzon, Nicanor Vega-Diaz, et al.Case Reports in Nephrology and Dialysis|July 30, 2021
Patiromer in a Patient with Severe Hyperkalemia on Incremental Hemodialysis with 1 Session per Week: A Case Report and Literature ReviewJosé C De La Flor, Javier Deira, Alexander Marschall, et al.Clinical Case Reports|October 17, 2022
Silent challenge: Early kidney transplant failure and cardiomyopathyRaquel Santana-Estupiñán, Francisco Valga, María Del Val Groba Marco, et al.Biomedicines|July 29, 2023
Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?José C De La Flor, Daniel Villa, Leónidas Cruzado, et al.Pageof 2